IL4 (Interleukin 4) Recombinant Human Protein
Product Image
Gibco™

IL4 (Interleukin 4) Recombinant Human Protein

Recombinant IL4 is a bioactive protein intended for use in cell culture applications. IL4 promotes the proliferation and differentiation ofMás información
Have Questions?
Número de catálogo CTP0041
Precio (CLP)
3.848.721
100 µg
Añadir al carro de la compra
Precio (CLP)
3.848.721
100 µg
Añadir al carro de la compra
Recombinant IL4 is a bioactive protein intended for use in cell culture applications. IL4 promotes the proliferation and differentiation of activated B cells. In addition, IL4 up-regulates class II MHC antigen expression and IgE receptors. ED50 = 0.05 to 0.4 ng⁄mL (Specific Activity: 2.0 x 10^7 to 2.5 x 10^6 units⁄mg). The biological activity is determined by measuring the dose-dependent proliferation of human TF-1 cells. A concentration range of 0.1 to 10.0 ng⁄mL is effective for most in vitro applications.
For Research Use Only. Not for use in diagnostic procedures.
Especificaciones
Actividad0.132 ng/ml
BioensayoProliferation of TF1 cells
ClasificaciónCarrier-Free
Nivel de endotoxinas< 0.1 ng/μg
Sistema de expresiónE. coli
Alias de genIL-4 (Interleukin 4)
Peso molecular14.9 kDa
Línea de productosGibco
Familia de proteínasCytokines & Receptors
Forma de proteínaFull Length, Recombinant, Ligand
Subtipo de proteínaInterleukins
Método de purificaciónGel-Purified
Grado de pureza o calidad95 %
Cantidad100 μg
ReactividadHuman
Categoría de investigaciónClinical Research, Stem Cell Research, Immunology, Inflammation
Condiciones de envíoWet Ice
Para utilizar con (aplicación)Cell Culture
RecombinanteRecombinant
EspecieHuman
Unit Size100 µg
Contenido y almacenamiento
Lyophilized protein can be stored at 2-8°C dessicated. Once reconstituted, store in aliquots at ≤20°C. Avoid multiple freeze⁄thaw cycles.

Preguntas frecuentes

It looks like the recombinant protein vial I received from you is empty. Is this normal?

Gibco recombinant proteins are frequently formulated without carrier proteins or additives (e.g., BSA, HSA, sucrose, etc.) and no Gibco PeproTech recombinant protein contains a carrier protein. As a result, during lyophilization, the protein product may be deposited on the vial as a thin, and sometimes invisible, film instead of a pellet. The size of the pellet, if any, is not directly related to the quantity of the recombinant protein in the vial. Our quality control procedures assure that each vial contains the correct amount of product.

To ensure complete recovery of protein product, before opening a vial of lyophilized recombinant protein, we recommend centrifuging it in a microcentrifuge for 20-30 seconds to drive any protein that may be lodged in the cap or on the side to the bottom of the vial. After reconstitution, you can confirm the presence of product protein by running a small amount on SDS-PAGE. In general, a protein band with expected size should be visible with as little as 10 ng of protein loaded on an acrylamide gel.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Why does my recombinant protein not show activity in my own experiment?

Assay time is critical. Each assay needs to beoptimized and performed at the peak response time. Different cells may respond differently to a growth factor or cytokine. We suggest repeating our QC assay using same indicator cells as suggested in the manual to see if you can obtain a similar response. In addition, serum may be masking the response. Serum starvation might be needed for certain types of assays.

How should I store the reconstituted recombinant proteins?

Protein solutions are generally not very stable when frozen at low concentration. Upon freeze and thaw, some proteins in the solution may stick to the wall of the container, which results in significant reduction of protein concentration if the starting concentration was low. Therefore, carrier proteins are used to reduce such loss. The most commonly used carrier proteins include bovine serum albumin (BSA), human serum albumin (HSA), or fetal bovine serum (FBS). These carrier proteins are generally used at 0.1% concentration. As a rule of thumb, if the concentration of the recombinant protein is less than 0.5 mg/mL, it is a good idea to add some carrier protein

How do I store my lyophilized recombinant protein?

Lyophilized proteins can typically be stored at 2 to 8 degrees C for several weeks, or stored dessicated at -20 degrees C for long-term storage.

Citations & References (6)

Citations & References
Abstract
Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells.
Authors:Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL, Blomberg BB,
Journal:J Immunol
PubMed ID:18390709
'Elderly humans have compromised humoral and cellular immune responses, which lead to reduced protection to infectious agents and to vaccines. Currently, available vaccines suboptimally protect the elderly population. The capacity to class switch the Ig H chain is critical to the effectiveness of humoral immune responses in mice and humans. ... More
SOCS2 influences LPS induced human monocyte-derived dendritic cell maturation.
Authors:Hu J, Winqvist O, Flores-Morales A, Wikström AC, Norstedt G
Journal:PLoS One
PubMed ID:19779605
'Dendritic cells (DCs) are highly specific antigen presenting cells, which link innate and adaptive immune responses and participate in protecting hosts from invading pathogens. DCs can be generated in vitro by culturing human monocytes with GM-CSF and IL-4 followed by LPS induced DC maturation. We set out to study the ... More
IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.
Authors:Hua X, Chason KD, Patel JY, Naselsky WC, Tilley SL,
Journal:PLoS One
PubMed ID:21966389
Adenosine inhalation produces immediate bronchoconstriction in asthmatics but not in normal subjects. The bronchospastic effect of adenosine is largely mediated through adenosine-induced mast cell activation, the mechanism of which is poorly understood due to limitations in culturing human primary mast cells. Here, we show that human umbilical cord blood -derived ... More
Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.
Authors:Pietrella D, Corbucci C, Perito S, Bistoni G, Vecchiarelli A
Journal:Infect Immun
PubMed ID:15664921
Our previous data show that mannoproteins (MPs) from Cryptococcus neoformans are able to induce protective responses against both C. neoformans and Candida albicans. Here we provide evidence that MPs foster maturation and activation of human dendritic cells (DCs). Maturation was evaluated by the ability of MPs to facilitate expression of ... More
Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1.
Authors:Unger WW, Laban S, Kleijwegt FS, van der Slik AR, Roep BO
Journal:Eur J Immunol
PubMed ID:19688742
Specific therapy with modulated DC may restore immunological tolerance, thereby obviating the need for chronic immunosuppression in transplantation or autoimmunity. In this study we compared the tolerizing capacity of dexamethasone (Dex)- and 1 alpha,25-dihydroxyvitamin D3 (VD3)-modulated DC. Treatment of monocytes with either VD3 or Dex resulted in DC with stable, ... More